Premarket Data Agreements Would Be Voided By "Significant" Changes - FDA
This article was originally published in The Gray Sheet
Executive Summary
Significant changes made by a manufacturer to a device or study design that is the subject of an "early collaboration" agreement with FDA would nullify the agreement, the agency says in a recent guidance.